Powered by The Ohio State University


Buprenorphine for Opioid Use Disorder


Welcome to the HECAOD podcast! Today’s episode is hosted by Dr. Ken Hale, Associate Director of the Higher Education Center, with guest, Dr. Mark Sirgo, President and Chief Executive Officer of BioDelivery Sciences.

Please join Dr. Hale and Dr. Sirgo as they discuss the use of buprenorphine and medication assisted treatment in treating opioid use disorder.

Podcast Guest: Dr. Mark Sirgo

sirgo bsdi 038




SAMHSA Advisory (2016) – Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update

Leave a Reply

Be the First to Comment!

Notify of

Our Founding Partners